滚环翻译的EGFR变体维持EGFR信号并促进胶质母细胞瘤致瘤性
本研究报道环状EGFR RNA(circ-EGFR)通过滚环翻译和程序性-1核糖体移码产生一种新型多聚蛋白复合物rtEGFR,可维持EGFR膜定位并减弱其内吞降解;在97例GBM样本中circ-EGFR水平与EGFR特征相关并预测不良预后,靶向rtEGFR可增强抗GBM效果。
要点
- circ-EGFR通过滚环翻译产生rtEGFR,维持EGFR信号并减少降解。
- circ-EGFR水平与GBM患者EGFR特征相关并预测不良预后。
- 靶向rtEGFR可减弱致瘤性并增强抗GBM疗效。
核心结论
- circ-EGFR编码的rtEGFR通过维持EGFR膜定位和减弱降解来持续激活EGFR信号,促进GBM致瘤性。
- 靶向rtEGFR可能提高GBM中EGFR靶向治疗的效率。
研究设计与样本
- 基础与转化研究,采用RNA-seq、Northern blot和Sanger测序确认circ-EGFR存在。
- 使用抗体和液相色谱串联质谱鉴定circ-EGFR蛋白产物。
- 用慢病毒转染的稳定细胞系在体外和体内评估新蛋白的生物学功能。
- 利用97例病理诊断的GBM患者样本评估circ-EGFR的临床意义。
主要发现
- circ-EGFR中的无限开放阅读框通过滚环翻译和-1PRF诱导的框外终止密码子翻译重复氨基酸序列,形成多聚新型蛋白复合物rtEGFR。
- rtEGFR直接与EGFR相互作用,维持EGFR膜定位并减弱EGFR内吞和降解。
- circ-EGFR水平与EGFR特征相关并预测GBM患者不良预后。
- 在脑肿瘤起始细胞中剥夺rtEGFR可减弱致瘤性并增强抗GBM效果。
临床怎么用
- circ-EGFR水平或可作为GBM预后预测的生物标志物。
- 靶向rtEGFR可能作为增强EGFR靶向治疗效果的联合策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Aberrant epidermal growth factor receptor (EGFR) activation is observed in over 50% of cases of adult glioblastoma (GBM). Nevertheless, EGFR antibodies are ineffective in clinical GBM treatment, suggesting the existence of redundant EGFR activation mechanisms. Whether circular RNA (circRNA) encodes a protein involved in EGFR-driven GBM remains unclear. We reported an unexpected mechanism in which circular EGFR RNA (circ-EGFR) encodes a novel EGFR variant to sustained EGFR activation. METHOD: We used RNA-seq, Northern blot, and Sanger sequencing to confirm the existence of circ-EGFR. Antibodies and a liquid chromatograph tandem mass spectrometer were used to identify circ-EGFR protein products. Lentivirus-transfected stable cell lines were used to assess the biological functions of the novel protein in vitro and in vivo. Clinical implications of circ-EGFR were assessed using 97 pathologically diagnosed GBM patient samples. RESULTS: The infinite open reading frame (iORF) in circ-EGFR translated repeating amino acid sequences via rolling translation and programmed -1 ribosomal frameshifting (-1PRF) induced out-of-frame stop codon (OSC), forming a polymetric novel protein-complex, which we termed rolling-translated EGFR (rtEGFR). rtEGFR directly interacted with EGFR, maintained EGFR membrane localization and attenuated EGFR endocytosis and degradation. Importantly, circ-EGFR levels correlated with the EGFR signature and predicted the poor prognosis of GBM patients. Deprivation of rtEGFR in brain tumor-initiating cells (BTICs) attenuated tumorigenicity and enhanced the anti-GBM effect. CONCLUSION: Our findings identified the endogenous rolling-translated protein and provided strong clinical evidence that targeting rtEGFR could improve the efficiency of EGFR-targeting therapies in GBM.
引用
- Liu Y, Li Z, Zhang M, et al. Rolling-translated EGFR variants sustain EGFR signaling and promote glioblastoma tumorigenicity. Neuro Oncol. 2021. PMID: 33325513. doi:10.1093/neuonc/noaa279
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。